1.) Milk thistle (Silybum marianum) for the therapy of liver disease

2.) Milk thistle in liver diseases: past, present, future

3.) Immunostimulatory effect of Silybum Marianum (milk thistle) extract

4.) Review of Clinical Trials Evaluating Safety and Efficacy of Milk Thistle (Silybum marianum [L.] Gaertn.)

5.) Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review

6.) Cisplatin Nephrotoxicity and Protection by Milk Thistle Extract in Rats

7.) Milk Thistle Nomenclature: Why It Matters in Cancer Research and Pharmacokinetic Studies

8.) Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease

9.) Silymarin (milk thistle extract) as a therapeutic agent in
gastrointestinal cancer

10.) Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling

11.) Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells

12.) Milk Thistle: Is There a Role for Its Use as an Adjunct Therapy in Patients with Cancer?

13.) Advances in the Use of Milk Thistle (Silybum marianum)

14.) Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia

15.) Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells

16.) Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy

17.) Targeting STAT3 with silibinin to improve cancer therapeutics